BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 6, Issue 7
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (13548)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.
Item 
Count 
PDF804
WORD267
HTML9424
Figures (1-5)517
Tables (1-1)446
 Sum=11458
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1182
Download908
 Sum=2090
Jul 27, 2014 (publication date) through Jul 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Samonakis DN, Koulentaki M, Coucoutsi C, Augoustaki A, Baritaki C, Digenakis E, Papiamonis N, Fragaki M, Matrella E, Tzardi M, Kouroumalis EA. Clinical outcomes of compensated and decompensated cirrhosis: A long term study. World J Hepatol 2014; 6(7): 504-512 [PMID: 25068002 DOI: 10.4254/wjh.v6.i7.504]
URL: https://www.wjgnet.com/1948-5182/full/v6/i7/504.htm
Number Citing Articles
1
Maaike Biewenga, Xavier P.D.M.J. Verhelst, Martine A.M.C. Baven‐Pronk, Hein Putter, Aad P. van den Berg, Karin C.M.J. van Nieuwkerk, Henk R. van Buuren, Gerd Bouma, Ynte S. de Boer, Cedric Simoen, Isabelle Colle, Jeoffrey Schouten, Filip Sermon, Christophe van Steenkiste, Hans van Vlierberghe, Adriaan J. van der Meer, Frederik Nevens, Bart van Hoek. Development and validation of a prognostic score for long‐term transplant‐free survival in autoimmune hepatitis type 1. United European Gastroenterology Journal 2021; 9(6): 662 doi: 10.1002/ueg2.12112
2
Ankur Srivastava, Simcha Jong, Anna Gola, Ruth Gailer, Sarah Morgan, Karen Sennett, Sudeep Tanwar, Elena Pizzo, James O’Beirne, Emmanuel Tsochatzis, Julie Parkes, William Rosenberg. Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1039-4
3
Tami Gurley, Ruben Hernaez, Vanessa Cerda, Tynaje Thomas, Manasa Narasimman, Sukul Mittal, Mohammed Al-Hasan, Darine Daher, Amit G. Singal. Cost-effectiveness of an outreach program for HCC screening in patients with cirrhosis: a microsimulation modeling study. eClinicalMedicine 2025; 81: 103113 doi: 10.1016/j.eclinm.2025.103113
4
Georgios N. Kalambokis, Nikolleta Chouliara, Ilias Tsiakas, Sempastien Filippas-Ntekuan, Maria Christaki, Grigorios Despotis, Haralampos Milionis. Impact of continued alcohol use on liver-related outcomes of alcohol-associated cirrhosis: a retrospective study of 440 patients. European Journal of Gastroenterology & Hepatology 2024; 36(1): 89 doi: 10.1097/MEG.0000000000002648
5
Marcelo Kugelmas, Michelle Loftus, Emily J Owen, Hani Wadei, Sammy Saab. Expert perspectives for the pharmacist on facilitating and improving the use of albumin in cirrhosis. American Journal of Health-System Pharmacy 2023; 80(13): 806 doi: 10.1093/ajhp/zxad070
6
Tamrat Petros Elias, Abate Bane Shewaye, Henok Fisseha, Abdulsemed Mohammed Nur, Kaleb Assefa Berhane, Asteray Tsige Minyilshewa, Kibrab Bulto Kumsa, Biruck Mohammed Seid, Alessandro Granito. Predictors of in-hospital mortality among cirrhotic patients in Ethiopia: A multicenter retrospective study. PLOS One 2025; 20(4): e0322532 doi: 10.1371/journal.pone.0322532
7
Tyler J. Reed, Danielle D'Ambrosio, Barbara E.C. Knollmann-Ritschel. Educational Case: Evaluating a patient with cirrhosis. Academic Pathology 2022; 9(1): 100031 doi: 10.1016/j.acpath.2022.100031
8
Elena Curakova Ristovska. Portal Hypertension - Recent Advances. 2021;  doi: 10.5772/intechopen.96172
9
Amit G. Singal, Jagpreet Chhatwal, Neehar Parikh, Elliot Tapper. Cost-Effectiveness of a Biomarker-Based Screening Strategy for Hepatocellular Carcinoma in Patients with Cirrhosis. Liver Cancer 2024; : 1 doi: 10.1159/000539895
10
Jingbiao Chen, Peng Xu, Kyle Kalutkiewicz, Yiyang Sheng, Fatima Warsame, Mahmoud-Adam Tahboub-Amawi, Jiahui Li, Jin Wang, Sudhakar K. Venkatesh, Richard L. Ehman, Vijay H. Shah, Douglas A. Simonetto, Meng Yin. Liver stiffness measurement by magnetic resonance elastography predicts cirrhosis and decompensation in alcohol-related liver disease. Abdominal Radiology 2024; 49(7): 2231 doi: 10.1007/s00261-024-04479-2
11
Lindsay A Sobotka, Khalid Mumtaz, Alice Hinton, Sean G Kelly, Lanla F Conteh, Anthony J Michaels, A. James Hanje, Michael R Wellner. Cannabis use may reduce healthcare utilization and improve hospital outcomes in patients with cirrhosis. Annals of Hepatology 2021; 23: 100280 doi: 10.1016/j.aohep.2020.10.008
12
Balakrishnan Bini, B. Vijayalakshmi, K. T. Shenoy, Joseph Kurian Mukkadan. Etiological Spectrum, Epidemiological Characteristics in Compensated and Decompensated Cirrhosis at First Presentation. Asian Journal of Pharmaceutical Research and Health Care 2023; 15(4): 329 doi: 10.4103/ajprhc.ajprhc_97_23
13
Konstantinos Arvanitakis, Theocharis Koufakis, Georgios Kalopitas, Stavros P. Papadakos, Kalliopi Kotsa, Georgios Germanidis. Management of type 2 diabetes in patients with compensated liver cirrhosis: Short of evidence, plenty of potential. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2024; 18(1): 102935 doi: 10.1016/j.dsx.2023.102935
14
Elsebeth Elmstrøm Jensen, Rikke Baltzer, Susanne Helle Bjerg, Palle Bager. Supportive care in end-stage liver disease: a clinical review. Gastrointestinal Nursing 2018; 16(6): 38 doi: 10.12968/gasn.2018.16.6.38
15
Behailu Terefe Tesfaye, Esayas Kebede Gudina, Dula Dessalegn Bosho, Teshale Ayele Mega, Chiara Lazzeri. Short-term clinical outcomes of patients admitted with chronic liver disease to selected teaching hospitals in Ethiopia. PLOS ONE 2019; 14(8): e0221806 doi: 10.1371/journal.pone.0221806
16
Cosmas Rinaldi Adithya Lesmana, Monica Raharjo, Rino A. Gani. Managing liver cirrhotic complications: Overview of esophageal and gastric varices. Clinical and Molecular Hepatology 2020; 26(4): 444 doi: 10.3350/cmh.2020.0022
17
Jae Hyun Yoon, Chung Hwan Jun, Jeong Han Kim, Eileen L. Yoon, Byung Seok Kim, Jeong Eun Song, Ki Tae Suk, Moon Young Kim, Seong Hee Kang. Changing Trends in Liver Cirrhosis Etiology and Severity in Korea: the Increasing Impact of Alcohol. Journal of Korean Medical Science 2021; 36(21) doi: 10.3346/jkms.2021.36.e145
18
Gennaro D’Amico, Giovanni Perricone. Prediction of Decompensation in Patients with Compensated Cirrhosis: Does Etiology Matter?. Current Hepatology Reports 2019; 18(2): 144 doi: 10.1007/s11901-019-00473-1
19
Jorge Simon, Alberto Ouro, Lolia Ala-Ibanibo, Natalia Presa, Teresa Cardoso Delgado, María Luz Martínez-Chantar. Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover. International Journal of Molecular Sciences 2019; 21(1): 40 doi: 10.3390/ijms21010040
20
Sehrish Kamal, Muhammad Ali Khan, Ankur Seth, George Cholankeril, Deepansh Gupta, Utkarsh Singh, Faisal Kamal, Colin W Howden, Christopher Stave, Satheesh Nair, Sanjaya K Satapathy, Aijaz Ahmed. Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology 2017; 112(10): 1495 doi: 10.1038/ajg.2017.170
21
Sachiyo Igata, Yuko Kono, Thomas Van Houten, Calvin T. Hang, Bruno R. Cotter, Monet G. Strachan, Nagisa Morikawa, Anthony N. DeMaria. Role of Quantitation of Saline Bubble Studies in Patients with Liver Cirrhosis. Ultrasound in Medicine & Biology 2023; 49(8): 1804 doi: 10.1016/j.ultrasmedbio.2023.04.003
22
Abdolamir Allameh, Reyhaneh Niayesh-Mehr, Azadeh Aliarab, Giada Sebastiani, Kostas Pantopoulos. Oxidative Stress in Liver Pathophysiology and Disease. Antioxidants 2023; 12(9): 1653 doi: 10.3390/antiox12091653
23
Revanth Kalluru, Sai Gadde, Rahul Chikatimalla, Thejaswi Dasaradhan, Jancy Koneti, Swathi priya Cherukuri. Cirrhotic Cardiomyopathy: The Interplay Between Liver and Heart. Cureus 2022;  doi: 10.7759/cureus.27969
24
Huttakan Navadurong, Kessarin Thanapirom, Salisa Wejnaruemarn, Thaninee Prasoppokakorn, Roongruedee Chaiteerakij, Piyawat Komolmit, Sombat Treeprasertsuk. Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis. World Journal of Gastroenterology 2023; 29(32): 4873-4882 doi: 10.3748/wjg.v29.i32.4873
25
Ramesh Kumar, Sudhir Kumar, Sabbu Surya Prakash. Compensated liver cirrhosis: Natural course and disease-modifying strategies. World Journal of Methodology 2023; 13(4): 179-193 doi: 10.5662/wjm.v13.i4.179
26
Suzanna Fitzpatrick, Hazel Dhates Asunio Domingo, Sarah Merrill Finke. The Care of the Decompensated Cirrhotic Patient. The Journal for Nurse Practitioners 2017; 13(4): 256 doi: 10.1016/j.nurpra.2016.11.026
27
Amoako Duah, Adwoa Agyei-Nkansah, Foster Osei-Poku, Francisca Duah, Bright Peprah Addo, Isabelle Chemin. Sociodemographic characteristics, complications requiring hospital admission and causes of in-hospital death in patients with liver cirrhosis admitted at a district hospital in Ghana. PLOS ONE 2021; 16(6): e0253759 doi: 10.1371/journal.pone.0253759
28
Ya-Chun Chang, Ying-Tang Fang, Hung-Cheng Chen, Chiung-Yu Lin, Yu-Ping Chang, Yi-Hsuan Tsai, Yu-Mu Chen, Kuo-Tung Huang, Huang-Chih Chang, Chin-Chou Wang, Meng-Chih Lin, Wen-Feng Fang. The Survival of Septic Patients with Compensated Liver Cirrhosis Is Not Inferior to That of Septic Patients without Liver Cirrhosis: A Propensity Score Matching Analysis. Journal of Clinical Medicine 2022; 11(6): 1629 doi: 10.3390/jcm11061629
29
Zachary R. Bergman, Greg J. Beilman. The Acute Management of Surgical Disease. 2022; : 487 doi: 10.1007/978-3-031-07881-1_35
30
Saad Saffo, Guadalupe Garcia‐Tsao, Tamar Taddei. SGLT2 inhibitors in patients with cirrhosis and diabetes mellitus: A tertiary center cohort study and insights about a potential therapeutic target for portal hypertension. Journal of Diabetes 2021; 13(3): 265 doi: 10.1111/1753-0407.13136
31
An-Hsun Chou, Ching-Chang Chen, Yu-Sheng Lin, Ming-Shyan Lin, Victor Chien-Chia Wu, Pei-Chi Ting, Shao-Wei Chen. A population-based analysis of endovascular aortic stent graft therapy in patients with liver cirrhosis. Journal of Vascular Surgery 2019; 69(5): 1395 doi: 10.1016/j.jvs.2018.06.225
32
Winston E. Abara, P. Spradling, Y. Zhong, A. Moorman, E. H. Teshale, L. Rupp, S. C. Gordon, M. Schmidt, J. A. Boscarino, Y. G. Daida, S. D. Holmberg. Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with Cirrhosis. Journal of Gastrointestinal Cancer 2020; 51(2): 461 doi: 10.1007/s12029-019-00255-4
33
Eric Lawitz, Fred Poordad, Julio A. Gutierrez, Maria Beumont, Greet Beets, Ann Vandevoorde, Pieter Van Remoortere, Donghan Luo, Leen Vijgen, Veerle Van Eygen, Mohamed Gamil. Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus‐infected patients: Long‐term follow‐up results from the open‐label, Phase II IMPACT study. Health Science Reports 2020; 3(2) doi: 10.1002/hsr2.145
34
Emma Nilsson, Harald Anderson, Konstantina Sargenti, Stefan Lindgren, Hanne Prytz. Clinical course and mortality by etiology of liver cirrhosis in Sweden: a population based, long‐term follow‐up study of 1317 patients. Alimentary Pharmacology & Therapeutics 2019; 49(11): 1421 doi: 10.1111/apt.15255
35
Sumeet K. Asrani, Lauren Hall, Vikrant Reddy, Gerald Ogola, Manhal Izzy. Comorbid Chronic Diseases and Survival in Compensated and Decompensated Cirrhosis: A Population-Based Study. American Journal of Gastroenterology 2022; 117(12): 2009 doi: 10.14309/ajg.0000000000001909
36
Lindsay A Sobotka, Carleen Spitzer, Alice Hinton, Anthony Michaels, A James Hanje, Khalid Mumtaz, Lanla F Conteh. Management of hepatic hydrothorax and effect on length of stay, mortality, cost, and 30‐day hospital readmission. Journal of Gastroenterology and Hepatology 2020; 35(4): 641 doi: 10.1111/jgh.14842
37
Elena Curakova Ristovska, Magdalena Genadieva-Dimitrova, Beti Todorovska. Survival in Patients with Liver Cirrhosis: A Prospective Study. PRILOZI 2023; 44(3): 41 doi: 10.2478/prilozi-2023-0045
38
Lynda C. Doward, Matthew Breckons, Maria-Magdalena Balp, James Twiss, Luke Vale, Lorraine McSweeney, Clifford A. Brass, Quentin M. Anstee, Arun J. Sanyal. NASH-CHECK patient-reported outcome instrument: evaluation of content and face validity for patients with metabolic dysfunction–associated steatohepatitis and compensated cirrhosis. Journal of Patient-Reported Outcomes 2025; 9(1) doi: 10.1186/s41687-025-00881-6
39
Hong Zhao, Qi Wang, Changling Luo, Ligai Liu, Wen Xie, Xingshun Qi. Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/9609731
40
Luka Vranić, Tin Nadarevic, Davor Štimac, Mirella Fraquelli, Cristina Manzotti, Giovanni Casazza, Agostino Colli. Liver and spleen stiffness as assessed by vibration controlled transient elastography for diagnosing clinically significant portal hypertension in comparison with other elastography-based techniques in adults with chronic liver disease. Cochrane Database of Systematic Reviews 2022; 2022(8) doi: 10.1002/14651858.CD015415
41
Parham Safaie, Mugilan Poongkunran, Ping-Ping Kuang, Asad Javaid, Carl Jacobs, Rebecca Pohlmann, Imad Nasser, Daryl TY Lau. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(12): 3404-3411 doi: 10.3748/wjg.v22.i12.3404
42
Khaled Al-Smadi, Ammar Qureshi, Michelle Buitrago, Besher Ashouri, Zeid Kayali, Dirk Uhlmann. Survival and Disease Progression in Older Adult Patients With Cirrhosis: A Retrospective Study. International Journal of Hepatology 2024; 2024(1) doi: 10.1155/2024/5852680
43
Frank T. Spradley, Jillian A. Smith, Barbara T. Alexander, Christopher D. Anderson. Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease. American Journal of Physiology-Endocrinology and Metabolism 2018; 315(5): E795 doi: 10.1152/ajpendo.00394.2017
44
E. Lawitz, F. Poordad, J. A. Gutierrez, T. N. Kakuda, G. Picchio, G. Beets, A. Vandevoorde, P. Van Remoortere, B. Jacquemyn, D. Luo, S. Ouwerkerk‐Mahadevan, L. Vijgen, V. Van Eygen, M. Beumont. Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus‐infected patients with decompensated liver disease. Journal of Viral Hepatitis 2017; 24(4): 287 doi: 10.1111/jvh.12645
45
Marlene López-Sánchez, Aleida Bautista-Santos, María del Pilar Milke-García, Aldo Allende-López, Rosalba Moreno-Alcántar, Segundo Morán. Nutritional Status and Incidence of Hepatocellular Carcinoma in Patients with Compensated Liver Cirrhosis. Archives of Medical Research 2025; 56(3): 103127 doi: 10.1016/j.arcmed.2024.103127
46
Elias Kouroumalis, Argyro Voumvouraki. Hepatitis C virus: A critical approach to who really needs treatment. World Journal of Hepatology 2022; 14(1): 1-44 doi: 10.4254/wjh.v14.i1.1
47
Jonathan N. Thomas, Joanna Roopkumar, Tushar Patel, Matias A. Avila. Machine learning analysis of volatolomic profiles in breath can identify non-invasive biomarkers of liver disease: A pilot study. PLOS ONE 2021; 16(11): e0260098 doi: 10.1371/journal.pone.0260098
48
Lindsay A Sobotka, Rohan M Modi, Akshay Vijayaraman, A James Hanje, Anthony J Michaels, Lanla F Conteh, Alice Hinton, Ashraf El-Hinnawi, Khalid Mumtaz. Paracentesis in cirrhotics is associated with increased risk of 30-day readmission. World Journal of Hepatology 2018; 10(6): 425-432 doi: 10.4254/wjh.v10.i6.425
49
Mai Abdel Moneim, Doaa H. Abdelaziz, Yosra Ibrahim Nagy, Amin Abdel Baki, Ahmed S. Attia, Nirmeen Sabry. Rifaximin microbial resistance and its efficacy and safety as a secondary prophylaxis of hepatic encephalopathy in patients with hepatitis C virus‐related cirrhosis. International Journal of Clinical Practice 2021; 75(11) doi: 10.1111/ijcp.14807
50
Hamza Tahir, Manisha Verma, Bakhtawer Siraj, Richard S. Kalman. Navigating Cirrhosis: Presentation, Outcomes, and Treatments in Adulthood and Beyond. Current Treatment Options in Gastroenterology 2024; 22(4): 218 doi: 10.1007/s11938-024-00461-5
51
Camille A. Kezer, Annalisa Berzigotti, Brett E. Fortune, Douglas A. Simonetto. Drug treatments to prevent first decompensation in cirrhosis. Hepatology 2024;  doi: 10.1097/HEP.0000000000001117
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345